{"id":404846,"date":"2025-07-27T01:05:00","date_gmt":"2025-07-26T23:05:00","guid":{"rendered":"https:\/\/medizinonline.com\/cosa-ce-di-nuovo-nella-strategia-pace-and-ablate\/"},"modified":"2025-07-14T10:49:03","modified_gmt":"2025-07-14T08:49:03","slug":"cosa-ce-di-nuovo-nella-strategia-pace-and-ablate","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/it\/cosa-ce-di-nuovo-nella-strategia-pace-and-ablate\/","title":{"rendered":"Cosa c&#8217;\u00e8 di nuovo nella strategia &#8220;pace-and-ablate&#8221;?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>La fibrillazione atriale (FA) \u00e8 l&#8217;aritmia cardiaca pi\u00f9 comune ed \u00e8 associata a una maggiore morbilit\u00e0 e mortalit\u00e0. La linea guida della <em>Societ\u00e0 Europea di Cardiologia<\/em> (ESC), aggiornata lo scorso anno, si avvale delle ultime evidenze per mostrare in quali casi la terapia farmacologica intensificata non \u00e8 sufficiente e in quali condizioni si dovrebbe prendere in considerazione l&#8217;impianto di un pacemaker in combinazione con l&#8217;ablazione del nodo atrioventricolare (AV). La strategia &#8220;pace-and-ablate&#8221; \u00e8 attualmente in fase di studio in diverse sottopopolazioni di pazienti con FA.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fcosa-ce-di-nuovo-nella-strategia-pace-and-ablate%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>La fibrillazione atriale (FA) \u00e8 l&#8217;aritmia cardiaca pi\u00f9 comune ed \u00e8 associata a una maggiore morbilit\u00e0 e mortalit\u00e0. La linea guida della Societ\u00e0 Europea di Cardiologia (ESC), aggiornata lo scorso&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fcosa-ce-di-nuovo-nella-strategia-pace-and-ablate%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":404850,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Fibrillazione atriale","footnotes":""},"category":[11366,11306,11522,11550,11515],"tags":[84070,84071,1620,17153,14792,24254,84072,23947,1577,40078],"powerkit_post_featured":[],"class_list":["post-404846","post","type-post","status-publish","format-standard","has-post-thumbnail","category-cardiologia-it","category-medicina-interna-generale","category-rapporti-del-congresso","category-rx-it","category-studi","tag-pace-e-ablato","tag-congresso-di-primavera-della-sgaim","tag-esc","tag-esc-it","tag-fibrillazione-atriale","tag-societa-europea-di-cardiologia","tag-societa-europea-di-cardiologia-it-2","tag-tachicardia","tag-vhf","tag-vhf-it","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-06-16 08:24:14","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"it_IT","wpml_translations":{"pt_PT":{"locale":"pt_PT","id":404857,"slug":"o-que-e-que-ha-de-novo-na-estrategia-pace-and-ablate","post_title":"O que \u00e9 que h\u00e1 de novo na estrat\u00e9gia \"pace-and-ablate\"?","href":"https:\/\/medizinonline.com\/pt-pt\/o-que-e-que-ha-de-novo-na-estrategia-pace-and-ablate\/"},"es_ES":{"locale":"es_ES","id":404848,"slug":"que-hay-de-nuevo-en-la-estrategia-pace-and-ablate","post_title":"\u00bfQu\u00e9 hay de nuevo en la estrategia \"pace-and-ablate\"?","href":"https:\/\/medizinonline.com\/es\/que-hay-de-nuevo-en-la-estrategia-pace-and-ablate\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/404846","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/comments?post=404846"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/404846\/revisions"}],"predecessor-version":[{"id":404851,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/404846\/revisions\/404851"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media\/404850"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media?parent=404846"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/category?post=404846"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/tags?post=404846"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/powerkit_post_featured?post=404846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}